Clinical Trials
2
Active:0
Completed:2
Trial Phases
1 Phases
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 3
1 (100.0%)Efficacy and Safety of Cinitapride Tablets in the Treatment of Mild to Moderate Functional Dyspepsia
- First Posted Date
- 2011-05-18
- Last Posted Date
- 2011-11-30
- Lead Sponsor
- Eisai China Inc.
- Target Recruit Count
- 400
- Registration Number
- NCT01355276
- Locations
- 🇨🇳
The First Affiliated Hospital of Anhui medical university, Hefei, Anhui, China
🇨🇳Huazhong University of Science and Technology of Tongji Hospital Affiliated Tongji Medical School, Wuhan, Hubei, China
🇨🇳Renmin Hospital of Wuhan University, Wuhan, Hubei, China
Drug Use Survey (DUS) of Triple Therapy (Methycobal (MBL)+ Myonal (MYO)+ Non-steroidal Anti-inflammatory Drags (NSAID)) on the Symptom Relief of Lumbar DDD in China
Completed
- Conditions
- Lumbar Disc Degenerative Disease
- First Posted Date
- 2011-02-18
- Last Posted Date
- 2011-12-28
- Lead Sponsor
- Eisai China Inc.
- Target Recruit Count
- 478
- Registration Number
- NCT01299077
- Locations
- 🇨🇳
Dongfang Hospital, Shanghai, Shanghai, China
🇨🇳Huashan Hospital, Shanghai, Shanghai, China
🇨🇳Ruijin Hospital, Shanghai, Shanghai, China
News
No news found